OptimizeRx Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 Sales Results and Issued FY24 Sales Guidance Below Estimates.
OptimizeRx Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 Sales Results and Issued FY24 Sales Guidance Below Estimates.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.